Tirzepatide: The First Weight Loss Drug for Sleep Apnea
A popular weight-loss medication has just become the first FDA-approved drug to effectively treat obstructive sleep apnea in adults with obesity.
Read AnalysisWidespread Sleep Loss During National Events Increases Influenza Risk
When major national events keep America awake at night, the resulting population-wide exhaustion drastically increases our collective risk of catching the flu.
Read AnalysisSpecific Air Pollution Particles Linked to Worse Sleep Apnea
A massive new study reveals that specific chemical components of air pollution, particularly black carbon, can directly exacerbate sleep apnea.
Read AnalysisLow Vitamin D Raises Heart Failure Risk in Sleep Apnea
If you have obstructive sleep apnea, a simple vitamin D deficiency could significantly increase your risk of developing heart failure.
Read AnalysisBrain's Nightly Wash Cycle Clears Alzheimer's Proteins in Humans
A new trial reveals that your brain actively flushes Alzheimer's-linked proteins into your bloodstream overnight.
Read AnalysisTirzepatide Slashes Heart Disease Risks in Sleep Apnea Patients
A popular weight loss medication doesn't just shed pounds; it significantly improves heart health and insulin resistance for people struggling with sleep apnea.
Read Analysis